|
Congress Urged to Include Biologics in Drug Shortage Mandates for Pharma Companies
Biologics, like small-molecule drugs, may soon be subject to early shortage notification requirements if a group of stakeholders convinces lawmakers to include them in pending user fee authorization bills.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives